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The Bao lab carried out fluorescence labeling and cellular delivery of magnetic 
nanoparticle probes, as indicated in the subcontract. Magnetic nanoparticles received 
from MagneSensors were labeled with a fluorescent dye and conjugated to a cell-
permeating peptide for delivery into Hela cells in culture. Some of these particles were 
also conjugated to an antibody for tubulin, in an effort to immobilize the particles once 
delivered into the cell. Magnetic Nanoparticles were delivered into cells and imaged at 
the Bao lab at Georgia Tech. When incubated with cells at high concentrations, 
nanoparticles were observed to agglomerate on the surface of cells. When incubated with 
cells at low concentrations, nanoparticles were observed inside cells, both in large, 
micron-sized clusters, and as smaller, individual dots. Some nanoparticle batches were 
also returned to MagneSensors to evaluate the possibility of real-time quantification of 
intracellular binding using a superconducting quantum interference device (SQUID) 
magnetometer. Some of the nanoparticle batches were reported to have dissolved en 
route to MagneSensors , possibly due to the presence of PBS. This effect was not 
observed at Georgia Tech. 
Nanopa r t i c l e Labe l ing a n d Conjuga t ion 
Fluorescence Labeling of Magnetic Nanoparticles 
Streptavidin-Captivate™ ferrofluid conjugate (Molecular Probes, Invitrogen Corp., 
Carlsbad, CA), 0.5 mg Fe/mL, was concentrated either with a Microcon® YMIO 
centrifugal filter unit or by magnetic separation using a small neodymium magnet to 
improve labeling efficiency and change into labeling buffer. Labeling buffer was 
phosphate buffered saline (PBS) with 10% 1M sodium bicarbonate. The fluorescent 
label used was amine-reactive Alexa 546 (Molecular Probes). Alexa 546 was reacted at 
8X molar excess the molar concentration of streptavidin on the surface of the particle 
(according to Molecular Probes, there are approximately 2500 streptavidin per particle). 
Reaction was done at room temperature with gentle shaking for two hours and then 
allowed to continue at 4°C overnight. Particles were washed with excess PBS to remove 
unreacted dye until supernatant had little residual fluorescence at 546 nm. Washes were 
performed in Y M 1 0 Microcons or with magnetic separation. 
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Conjugation of Tat Peptide and Anti-Tubulin Antibody 
Biotinylated Tat Peptide (N terminus-TyrGlyArgLysLysArgArgGlnArgArgArg-Lys-
Ahx-biotin) and biotinylated tubulin antibody were reacted with fluorescently labeled, 
streptavidin-coated Captivate. The actual conjugation procedure consisted of simply 
mixing the labeled Captivate gently (with vortexer) with the desired concentration of Tat, 
Ab or Tat and Ab mixture for one hour at room temperature. Several different 
concentrations were explored to optimize delivery and intracellular immobilization. For 
Tat peptide, concentrations ranged from 10 Tat peptides per calculated biotin site to 2 Tat 
peptides per magnetic particle. For the tubulin antibody, concentrations ranged from 3 
antibodies per calculated biotin site to 2 antibodies per particle. Some reactions were 
performed in the presence of biotin (ranging from 1.5 X to 30X excess of the biotin sites) 
to avoid crosslinking when reacting with the multiply-biotinylated antibody. 
Delivery of Labeled Captivate into Cells 
Captivate labeled with Alexa 546, Tat peptide, and/or tubulin antibody were incubated 
with Hela cells to determine delivery efficiency and immobilization properties. Alexa-
Captivate-Tat-(Ab) was mixed with Hela D M E M media in ratios ranging from 1:4 to . 
Medium was removed from the well of a 4-well plate and replaced with the Alexa-
Captivate media and incubated for one hour at 37°C. After incubation, cells were washed 
with OptiMem (a reduced serum medium that lessens autofluorescence) and observed 
under a light microscope, a fluorescent microscope (40X and 100X) and sometimes a 
confocal fluorescent microscope. 
Resul ts and Discussion 
The initial experiment for delivering Alexa-Captivate-Ab-Tat nanoparticles were carried 
out using nanoparticles that reacted with approximately 10 Tat peptides per biotin site; 
they were delivered into cells at high concentrations (1:4 or 1:8 Captivate to media ratio). 
Under both the light microscope and fluorescent microscope, it was apparent that these 
particles were clustered (micron-sized aggregates) all over the outside surface of the cell, 
but were not removable with washing. A control delivery experiment was performed by 
incubating with Hela cells the unlabeled Captivate without Tat conjugated to the surface, 
and no such aggregation was observed. However, when unlabeled Captivate was 
conjugated to Tat and then incubated as described above, micro-sized iron oxide clusters 
were visible on the surface of the cells in the light microscope. 
To eliminate clustering on the surface of cells, two concurrent approaches were used. 
The amount of Tat peptide conjugated to the surface of the Captivate was dramatically 
reduced (roughly two Tat per particle) and the concentration of Alexa-Captivate-Tat was 
also reduced (1:30 Captivate:media). This preparation showed no evidence of cell 
surface aggregation, and imaging with the fluorescent microscope revealed evidence of 
Alexa-Captivate inside the Hela cells. Many large, bright aggregates (micron-sized) were 
visualized. Dimmer, smaller (submicron) fluorescent spots were also observed, 
suggesting the presence of two classes of internalized Captivate particles: (1) aggregates 
and (2) individual particles. 
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Labeled, conjugated particles were shipped to MagneSensors in California from Georgia 
Tech for SQUID examination. Upon receipt of the first package of labeled particles, the 
researchers from MagneSensors inspected the conjugated particles and reported that the 
particle concentration was significantly reduced from the original concentration shipped, 
i.e. the particles were likely dissolving over time. This was not observed in the Bao lab at 
Georgia Tech. After discussion with Molecular Probes, the MagneSensors researchers 
decided that PBS at low particle concentration might lead to nanoparticle dissolution. 
A final batch of particles was prepared for MagneSensors , prepared in sodium 
bicarbonate buffer with two different concentrations of Tat peptide, based on experiments 
performed at MagneSensors . A High-Tat preparation contained approximately 1000 Tat 
peptides per particle, 10 antibodies per particle, and 3X excess biotin per binding site. A 
Low-Tat preparation differed only in that it contained 10 Tat peptides per particle. In an 
effort to rule out any role that the Alexa dye might be playing in the dissolution of 
particles, unlabeled Captivate was also conjugated for both a High-Tat and Low-Tat 
preparation. It was not clear whether or not these preparations yielded good results. 
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